Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
Title:
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
Author:
Cefalu, William T Leiter, Lawrence A Yoon, Kun-Ho Arias, Pablo Niskanen, Leo Xie, John Balis, Dainius A Canovatchel, William Meininger, Gary